TrialCardiovascular diabetology2015

Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study.

Rafael Simó et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.